{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:43:12Z","timestamp":1791499392447,"version":"4.3.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103410","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T09:38:24Z","timestamp":1694943504000},"page":"103410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3107-6668","authenticated-orcid":false,"given":"Florence","family":"Nguyen-Khac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Chauzeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.retram.2023.103410_bib0001","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1097\/HS9.0000000000000473","article-title":"Diagnosis and treatment of chronic lymphocytic leukemia: recommendations of the French CLL study group (FILO)","volume":"4","author":"Quinquenel","year":"2020","journal-title":"HemaSphere"},{"issue":"25","key":"10.1016\/j.retram.2023.103410_bib0002","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.retram.2023.103410_bib0003","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0004","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0005","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/ajh.25956","article-title":"The complex karyotype and chronic lymphocytic leukemia: prognostic value and diagnostic recommendations","volume":"95","author":"Jondreville","year":"2020","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.retram.2023.103410_bib0006","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am J Hematol"},{"issue":"34","key":"10.1016\/j.retram.2023.103410_bib0007","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1200\/JCO.20.00948","article-title":"Venetoclax plus rituximab in relapsed chronic lymphocytic leukemia: 4-year results and evaluation of impact of genomic complexity and gene mutations from the MURANO phase III study","volume":"38","author":"Kater","year":"2020","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.retram.2023.103410_bib0008","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1182\/blood.2020010536","article-title":"The impact of increasing karyotypic complexity and evolution on survival in CLL patients treated with ibrutinib","volume":"138","author":"Kittai","year":"2021","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0009","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3324\/haematol.2021.280376","article-title":"A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib","volume":"107","author":"Mato","year":"2022","journal-title":"Haematologica"},{"issue":"36","key":"10.1016\/j.retram.2023.103410_bib0010","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1200\/JCO.21.01181","article-title":"Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: extended off-treatment follow-up from the randomized CLL14 study","volume":"39","author":"Al-Sawaf","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"5","key":"10.1016\/j.retram.2023.103410_bib0011","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/blood.2023019634","article-title":"High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations","volume":"142","author":"F\u00fcrstenau","year":"2023","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103410_bib0012","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/leu.2017.100","article-title":"Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1","volume":"31","author":"Cosson","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.retram.2023.103410_bib0013","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1038\/ncomms11589","article-title":"Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition","volume":"7","author":"Burger","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.retram.2023.103410_bib0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.23618","article-title":"Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data","volume":"89","author":"Baliakas","year":"2014","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.retram.2023.103410_bib0015","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/gcc.22188","article-title":"Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome","volume":"53","author":"Puiggros","year":"2014","journal-title":"Genes Chromosom Cancer"},{"issue":"4","key":"10.1016\/j.retram.2023.103410_bib0016","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.retram.2023.103410_bib0017","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0018","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.retram.2023.103410_bib0019","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2141.2009.07982.x","article-title":"A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia","volume":"148","author":"Van Dyke","year":"2010","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0020","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","article-title":"Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia","volume":"118","author":"Ouillette","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/leu.2013.263","article-title":"SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients","volume":"28","author":"Jeromin","year":"2014","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.retram.2023.103410_bib0022","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0023","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/leu.2008.102","article-title":"The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia","volume":"22","author":"Chapiro","year":"2008","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.retram.2023.103410_bib0024","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.leu.2404695","article-title":"A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation","volume":"21","author":"Mart\u00edn-Subero","year":"2007","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-011-1393-y","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course","volume":"91","author":"Put","year":"2012","journal-title":"Ann Hematol"},{"issue":"8","key":"10.1016\/j.retram.2023.103410_bib0026","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/gcc.22176","article-title":"14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma","volume":"53","author":"Cosson","year":"2014","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0027","first-page":"13","article-title":"Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia","volume":"1","author":"Nguyen-Khac","year":"2011","journal-title":"Am J Blood Res"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib0028","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2141.1996.d01-1478.x","article-title":"Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients","volume":"92","author":"Matutes","year":"1996","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib0029","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","article-title":"NOTCH1 mutations in CLL associated with trisomy 12","volume":"119","author":"Balatti","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3324\/haematol.2018.195032","article-title":"Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia","volume":"104","author":"Baliakas","year":"2019","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0030","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/gcc.22650","article-title":"Mutational and cytogenetic analyses of 188 CLL patients with trisomy 12: a retrospective study from the French Innovative Leukemia Organization (FILO) working group","volume":"57","author":"Roos-Weil","year":"2018","journal-title":"Genes Chromosom Cancer"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0031","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.retram.2023.103410_bib0032","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2004-11-4516","article-title":"Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL","volume":"106","author":"Austen","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103410_bib0033","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0034","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/cam4.2123","article-title":"Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug-resistant chronic lymphocytic leukemia","volume":"8","author":"Kostopoulou","year":"2019","journal-title":"Cancer Med"},{"issue":"7","key":"10.1016\/j.retram.2023.103410_bib0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41408-021-00520-5","article-title":"Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression","volume":"11","author":"Quijada-\u00c1lamo","year":"2021","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.retram.2023.103410_bib0036","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2009-03-210591","article-title":"De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience","volume":"114","author":"Tam","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103410_bib0037","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.24990","article-title":"Double-hit\u201d chronic lymphocytic leukemia: an aggressive subgroup with 17p deletion and 8q24 gain","volume":"93","author":"Chapiro","year":"2018","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cancergencyto.2006.01.005","article-title":"Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia","volume":"167","author":"Fink","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.retram.2023.103410_bib0039","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.canlet.2017.08.041","article-title":"Chronic lymphocytic leukemia with isochromosome 17q: an aggressive subgroup associated with TP53 mutations and complex karyotypes","volume":"409","author":"Collado","year":"2017","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.20.00979","article-title":"Prediction of outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: development and validation of a four-factor prognostic model","volume":"39","author":"Ahn","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.retram.2023.103410_bib0041","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3324\/haematol.2018.187583","article-title":"TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics","volume":"103","author":"Campo","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0042","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.leukres.2009.03.042","article-title":"Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages","volume":"34","author":"Chapiro","year":"2010","journal-title":"Leuk Res"},{"issue":"7574","key":"10.1016\/j.retram.2023.103410_bib0043","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.retram.2023.103410_bib0044","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","article-title":"High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations","volume":"120","author":"Edelmann","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3324\/haematol.2019.239947","article-title":"Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study","volume":"106","author":"Leeksma","year":"2021","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.retram.2023.103410_bib0046","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-11-2342","article-title":"Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia","volume":"18","author":"Brown","year":"2012","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.retram.2023.103410_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.859618","article-title":"Duplication of 8q24 in chronic lymphocytic leukemia: cytogenetic and molecular biologic analysis of MYC aberrations","volume":"12","author":"Ondrou\u0161kov\u00e1","year":"2022","journal-title":"Front Oncol"},{"issue":"49","key":"10.1016\/j.retram.2023.103410_bib0048","doi-asserted-by":"crossref","first-page":"80916","DOI":"10.18632\/oncotarget.13106","article-title":"Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations","volume":"7","author":"Blanco","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.retram.2023.103410_bib0049","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cancergen.2016.08.007","article-title":"MYC rearranged B-cell neoplasms: impact of genetics on classification","volume":"209","author":"Haberl","year":"2016","journal-title":"Cancer Genet"},{"issue":"12","key":"10.1016\/j.retram.2023.103410_bib0050","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103410_bib0051","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2008.07373.x","article-title":"Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion","author":"Forconi","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.retram.2023.103410_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-023-02035-3","article-title":"del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia","author":"Jondreville","year":"2023","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.retram.2023.103410_bib0053","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/10428194.2013.845882","article-title":"Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia","volume":"55","author":"Houldsworth","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.retram.2023.103410_bib102","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/blood.2022016600","article-title":"Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples","volume":"142","author":"Khalsa","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103410_bib0054","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood-2016-01-691550","article-title":"Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy","volume":"128","author":"Herling","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0055","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3324\/haematol.2018.212571","article-title":"Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia","volume":"106","author":"Heerema","year":"2021","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.retram.2023.103410_bib0056","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/ijc.33235","article-title":"Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications","volume":"147","author":"P\u00e9rez-Carretero","year":"2020","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib0057","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2005-05-2093","article-title":"Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia","volume":"107","author":"Mayr","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0058","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/leu.2009.44","article-title":"Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia","volume":"23","author":"Put","year":"2009","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.retram.2023.103410_bib0059","doi-asserted-by":"crossref","first-page":"E604","DOI":"10.1002\/ajh.24852","article-title":"Chromosome 6q deletion correlates with poor prognosis and low relative expression of FOXO3 in chronic lymphocytic leukemia patients","volume":"92","author":"Jarosova","year":"2017","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.retram.2023.103410_bib0060","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2401499","article-title":"Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia","volume":"13","author":"Stilgenbauer","year":"1999","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103410_bib0061","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3324\/haematol.2020.274456","article-title":"Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients","volume":"107","author":"Ramos-Campoy","year":"2021","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.retram.2023.103410_bib0062","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/sj.leu.2404739","article-title":"Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL","volume":"21","author":"Pospisilova","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0063","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2353\/jmoldx.2007.060088","article-title":"Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events","volume":"9","author":"Wlodarska","year":"2007","journal-title":"J Mol Diagn JMD"},{"issue":"7","key":"10.1016\/j.retram.2023.103410_bib0064","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ajh.26578","article-title":"TRAF3 alterations are frequent in del-3\u2019IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features","volume":"97","author":"P\u00e9rez-Carretero","year":"2022","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.retram.2023.103410_bib0065","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.3324\/haematol.2015.140202","article-title":"Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference","volume":"101","author":"Baliakas","year":"2016","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0066","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41375-022-01561-w","article-title":"The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)","volume":"36","author":"Nguyen-Khac","year":"2022","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.retram.2023.103410_bib0067","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood-2017-03-772285","article-title":"In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI","volume":"129","author":"Rigolin","year":"2017","journal-title":"Blood."},{"issue":"33","key":"10.1016\/j.retram.2023.103410_bib0068","doi-asserted-by":"crossref","first-page":"54297","DOI":"10.18632\/oncotarget.17350","article-title":"Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53\/ATM FISH deletions","volume":"8","author":"Puiggros","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0069","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0070","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/leu.2016.134","article-title":"Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia","volume":"30","author":"Parker","year":"2016","journal-title":"Leukemia"},{"issue":"15","key":"10.1016\/j.retram.2023.103410_bib0071","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3390\/cancers14153715","article-title":"TP53 abnormalities are underlying the poor outcome associated with chromothripsis in chronic lymphocytic leukemia patients with complex karyotype","volume":"14","author":"Ramos-Campoy","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.retram.2023.103410_bib0072","first-page":"329","article-title":"The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment","volume":"2017","author":"Gaidano","year":"2017"},{"issue":"5","key":"10.1016\/j.retram.2023.103410_bib0073","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/leu.2012.357","article-title":"NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome","volume":"27","author":"Villamor","year":"2013","journal-title":"Leukemia"},{"issue":"18","key":"10.1016\/j.retram.2023.103410_bib0074","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2015-05-647578","article-title":"Presence of multiple recurrent mutations confers poor trial outcome of relapsed\/refractory CLL","volume":"126","author":"Gui\u00e8ze","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103410_bib0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/leu.2017.291","article-title":"Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia","volume":"32","author":"Nadeu","year":"2018","journal-title":"Leukemia"},{"issue":"29","key":"10.1016\/j.retram.2023.103410_bib0076","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 mutation and survival in chronic lymphocytic leukemia","volume":"28","author":"Zenz","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.retram.2023.103410_bib0077","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.3390\/cancers14122997","article-title":"Multiple mechanisms of NOTCH1 activation in chronic lymphocytic leukemia: NOTCH1 mutations and beyond","volume":"14","author":"Pozzo","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.retram.2023.103410_bib0078","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa2114110","article-title":"Mechanisms of resistance to noncovalent Bruton's tyrosine kinase inhibitors","volume":"386","author":"Wang","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.retram.2023.103410_bib0079","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1182\/blood.2019004205","article-title":"Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax","volume":"135","author":"Blombery","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103410_bib0080","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.829983","article-title":"Biology and treatment of Richter transformation","volume":"12","author":"Condoluci","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0081","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/bjh.18352","article-title":"Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome","volume":"198","author":"Favini","year":"2022","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.retram.2023.103410_bib0082","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2021.278304","article-title":"The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation","volume":"107","author":"Visentin","year":"2022","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.retram.2023.103410_bib0083","doi-asserted-by":"crossref","first-page":"E311","DOI":"10.1002\/ajh.26239","article-title":"Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: a study of the French innovative leukemia organization","volume":"96","author":"Moulin","year":"2021","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.retram.2023.103410_bib0084","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"15","key":"10.1016\/j.retram.2023.103410_bib0085","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0086","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41591-022-02113-6","article-title":"Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome","volume":"29","author":"Parry","year":"2023","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.retram.2023.103410_bib0087","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3324\/haematol.2019.231027","article-title":"Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)","volume":"105","author":"Jaramillo","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2023.103410_bib0088","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.leukres.2009.11.003","article-title":"Increased trisomy 12 frequency and a biased IgVH 3-21 gene usage characterize small lymphocytic lymphoma","volume":"34","author":"Daudignon","year":"2010","journal-title":"Leuk Res"},{"issue":"12","key":"10.1016\/j.retram.2023.103410_bib0097","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3324\/haematol.2018.190132","article-title":"Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways","volume":"103","author":"Abruzzo","year":"2018","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.retram.2023.103410_bib0098","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-0609.1997.tb00944.x","article-title":"Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia","volume":"58","author":"Merup","year":"1997","journal-title":"Eur J Haematol"},{"issue":"28","key":"10.1016\/j.retram.2023.103410_bib0099","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2006.06.9492","article-title":"Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia","volume":"24","author":"Shanafelt","year":"2006","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib0100","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2141.2007.06636.x","article-title":"Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia","volume":"138","author":"Sellmann","year":"2007","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0089","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.2011.09010.x","article-title":"Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL","volume":"157","author":"Kern","year":"2012","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.retram.2023.103410_bib0091","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1038\/bcj.2017.77","article-title":"Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis","volume":"7","author":"Kostopoulos","year":"2017","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.retram.2023.103410_bib0092","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1097\/HS9.0000000000000707","article-title":"Cytogenetics in chronic lymphocytic leukemia: ERIC perspectives and recommendations","volume":"6","author":"Baliakas","year":"2022","journal-title":"HemaSphere"},{"issue":"1","key":"10.1016\/j.retram.2023.103410_bib0093","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"14","key":"10.1016\/j.retram.2023.103410_bib0094","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3390\/cancers14143376","article-title":"Optical genome mapping: a promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL)","volume":"14","author":"Puiggros","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.retram.2023.103410_bib0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.retram.2023.103410_bib0096","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.2020009813","article-title":"The CLL international prognostic index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL","volume":"138","author":"Parikh","year":"2021","journal-title":"Blood"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245231862300034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245231862300034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:41:56Z","timestamp":1762821716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245231862300034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S245231862300034X"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103410","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103410"}}